Australian Pharmaceuticals & Biotech High Growth Potential Companies

Acrux

Market Cap: AU$6.1m

Engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.

Mesoblast

Market Cap: AU$3.1b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Immutep

Market Cap: AU$374.3m

A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.

Botanix Pharmaceuticals

Market Cap: AU$284.4m

Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.

PYC Therapeutics

Market Cap: AU$737.8m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

Telix Pharmaceuticals

Market Cap: AU$5.8b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Medical Developments International

Market Cap: AU$80.0m

Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.

Aroa Biosurgery

Market Cap: AU$217.4m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

EZZ Life Science Holdings

Market Cap: AU$109.9m

Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.

Trajan Group Holdings

Market Cap: AU$140.9m

Develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India.

CSL

Market Cap: AU$130.8b

Researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.